12th International Symposium on Bordetella
第12届博德特氏菌国际研讨会
基本信息
- 批准号:9761709
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-05 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAdvertisingAnimal Disease ModelsAnimalsAwardBelgiumBiologyBordetellaBordetella pertussisClinicalCollaborationsCommunitiesCommunity NetworksCountryDeveloping CountriesDevelopmentDiseaseDomestic AnimalsEpidemiologistEpidemiologyEvolutionFosteringFundingFunding OpportunitiesFutureGenomicsHumanImmune responseImmunizationIndividualIndustryInfectionInternationalManufacturer NameMedicineMicrobiologyNotificationOralParticipantPathogenesisPertussisPertussis VaccinePhysiciansPostdoctoral FellowPreventionPrevention strategyProcessPublic HealthRecording of previous eventsResearchResearch PersonnelScientistStudentsTherapeuticTimeTravelUnderrepresented MinorityUniversitiesVaccine DesignVaccinesVirulence Factorsdata exchangedisease transmissiongraduate studentinnovationmeetingsnext generationnovelnovel vaccinespathogenpathogenic bacteriaposterspre-doctoralsymposiumtraining opportunitytranslational scientistvaccine developmentweb site
项目摘要
Project Summary/Abstract: Pertussis or whooping cough was once considered a disease of
the past but it is now one of the least controlled vaccine preventable diseases. Pertussis is
primarily caused by the Gram negative pathogen, Bordetella pertussis, but several other
Bordetellae cause similar diseases in humans as well as animals. The reemergence of
pertussis correlates with the transition to the acellular pertussis vaccines (DTaP and Tdap) in
the early 1990s. Since the 1960's the Bordetella research community has organized
international meetings which provide an opportunity for trainees, physicians, scientists,
epidemiologists, public health officials, and vaccine manufacturers to assemble and focus on
the problems together to move forward. The International Symposium occurs on a three-four
year cycle. The International Bordetella Symposium has served to build collaborations,
exchange ideas, establish priorities, and facilitate training opportunities for the next generation
of scientists. At the 11th symposium there were 50 oral presentations and 110 posters
presented by 196 attendees from 20 total countries. The 12th Symposium will be held at
Brussels University and will be hosted by Prof. Françoise Mascart and Dr. Camille Locht. The
organizing committee made up of 11 internationally known scientists who will directly participate
in the planning and administration of meeting. It is expected the 12th symposium will host 300
participants. The meeting agenda includes: Bordetella biology, genomics, evolution,
epidemiology, pathogenesis and virulence factors, animal models of disease and transmission,
immune responses to infection and immunization, vaccine design, as well as other important
topics. While there are numerous meetings that discuss bacterial pathogens, this is the only
symposium that exclusively focuses on Bordetella. In order to support development of the next
generation of scientists, this R13 application is requesting funds to support travel awards for
junior scientists (pre- and post-doctoral) to attend and present innovative research at the
12th International Bordetella Symposium in April 2019.
项目摘要/摘要:百日咳或百日曲曾经被认为是
过去,它是最不可控制的疫苗
主要是由革兰氏阴性病原体Bordetella buttussis引起的,但其他几个
Bordetelae在人类和动物中引起类似的疾病
百日咳与向细胞的百日咳疫苗(DTAP和TDAP)的过渡相关
1990年代初期。
国际会议为受训人员,医师,科学家,
流行病学家,公共卫生官员和疫苗制造,以组装和关注
共同前进的问题。
一年的周期。
交换想法,确定优先事项并促进下一代培训机会
科学家在第11次研讨会上
由20个国家的196名参与者举行。
Brassels University将由FrançoiseMascart教授和Camille Lockt博士主持
由11位国际知名科学家组成的组织委员会将直接参与
在会议的计划和管理中。
会议议程包括:Bordetella生物学,基因组学,进化
流行病学,发病机理和病毒因素,疾病和传播的动物模型,
对感染和免疫的免疫反应,疫苗设计以及其他重要的
主题。
专门侧重于边界以支持下一个发展的研讨会。
一代科学家
初级科学家(博士后和博士后)参加并在
2019年4月,第12届国际Bordetella研讨会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric T Harvill其他文献
Eric T Harvill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric T Harvill', 18)}}的其他基金
An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia
研究百日咳博德特氏菌与呼吸道上皮细胞相互作用的气液界面系统
- 批准号:
10665943 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
- 批准号:
10375566 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis
无细胞疫苗是否会导致缺乏百日咳博德特氏菌的增加
- 批准号:
10364771 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
- 批准号:
10194677 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
In vivo vaccine-driven evolution in Bordetella pertussis
百日咳博德特氏菌体内疫苗驱动的进化
- 批准号:
8986495 - 财政年份:2015
- 资助金额:
$ 0.5万 - 项目类别:
Systematic evaluation of B. pertussis ACT’s role as a protective antigen
百日咳博德特氏菌 ACT 作为保护性抗原的作用的系统评估
- 批准号:
9056231 - 财政年份:2015
- 资助金额:
$ 0.5万 - 项目类别:
Evolution of the Bordetellae from Commensals to Pathogens
博德特氏菌从共生菌到病原体的进化
- 批准号:
7886472 - 财政年份:2009
- 资助金额:
$ 0.5万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Applied Curriculum in Gender and Equity Skills (ACES)
性别与平等技能应用课程(ACES)
- 批准号:
10731498 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
2023 Epithelial Differentiation and Keratinization GRC & GRS
2023 上皮分化和角化GRC
- 批准号:
10608540 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
2022 Immunoengineering Gordon Research Conference
2022年免疫工程戈登研究会议
- 批准号:
10462069 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
RETAIN: A digital therapeutic for Alzheimer's risk reduction
RETAIN:降低阿尔茨海默病风险的数字疗法
- 批准号:
10256502 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别: